 Home > Active Ingredient News > Antitumor Therapy > European Radiology: Which imaging metric enables accurate prediction of invasive breast cancer?

European Radiology: Which imaging metric enables accurate prediction of invasive breast cancer?

 Last Update: 2022-10-12
 Source: Internet
 Author: User

Tags

size 90

breast hyperplasia

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

At this stage, it is clinically recommended that women undergo breast cancer screening at the age of 40 to reduce breast cancer mortality

Most breast cancers are invasive (81%), and more than 90% are invasive ductal carcinoma (IDC) and/or invasive lobular carcinoma (ILC

Recently, a study published in the European Journal of Radiology explored the qualitative and quantitative characteristics of breast lesions found by mammography examination and DBT, and further evaluated the diagnostic value of the two methods in predicting the nature of benign and malignant lesions, which provided a reference for

This study reviewed patients who underwent digital breast tombosynthetic techniques for further examination from 2017 to 2020 for mammography screening for breast lesions, and the lesions were biopsied

This performance eventually included 28 patients with invasive ductal carcinoma or invasive lobular cancer and 40 patients with

This study shows that the volume doubling time of mammography screening lesions is an important indicator

Original source:

Negar Sadeghipour,Joseph Tseng,Kristen Anderson,et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Bulk Peptides Kisspeptin 10 (human) /Kisspeptin 10/ Kisspeptin-10 Acetate CAS 374675-21-5

CAS No.: 374675-21-5

Pharmacy Grade

$10-13/UNIT FOB

Cediranib

CAS No.: 288383-20-0

$22/KG EXW

Upadacitinib hemihydrate API

CAS No.: 2050057-56-0

Pharmacy Grade

$35-45/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.